For each medication, the proportion of individuals meeting the FDA label indication who also met trial exclusion criteria was calculated. (HealthDay News) — About one-third of US adults without ...

Please provide your email address to receive an email when new articles are posted on . “For instance, HIV positivity, as well as hepatitis B and C positivity, were commonly cited exclusion criteria ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Up to 33.1% of adults eligible for GLP-1 receptor ...

About a third of people eligible for glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications for weight loss via the products’ labels would have been excluded from the clinical trials that ...

In the article that accompanies this editorial, Riner et al 1 apply pancreatic cancer clinical trial eligibility criteria to a real-world cohort of patients, finding that Black patients are less ...